Stocks

These Programs Support the Advancement of Tonopah West Towards the Permitting of an Exploration Decline to Enable Test Mining and the Extraction of a Bulk Sample HIGHLIGHTS: The Phase 2 hydrology program will consist of placing 5 additional piezometers, a dewatering well and a …

As global markets navigate a volatile landscape marked by easing monetary policies from the U.S. Federal Reserve and fluctuating trade tensions, small-cap stocks have shown resilience, with indices like the Russell 2000 reflecting a notable year-to-date increase. In this environment, identifying promising small-cap opportunities …

Argentina Lithium & Energy has disclosed the inaugural mineral resource estimate (MRE) for the Rincon West lithium brine project in Salta Province, Argentina. The findings indicate measured and indicated resources consisting of 0.15km³ brine volume with an average grade of 296mg of lithium, corresponding …

Veris Residential (VRE) reported $73.44 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 7.7%. EPS of $0.20 for the same period compares to -$0.10 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $74.99 …

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. Sometimes these stories can cloud …

Vancouver, British Columbia--(Newsfile Corp. - October 22, 2025) - Blackrock Silver Corp. (TSXV: BRC) (the "Company" or "Blackrock") is pleased to announce that it has filed on SEDAR+ an independent technical report titled "Mineral Resource Estimate Update, Tonopah West Silver-Gold Project" effective August 25, …

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ QUEBEC, Oct. 22, 2025 /CNW/ - Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXV: GSD) (OTCQB: DVHGF), a biopharmaceutical corporation specializing in the development of prescription drugs targeting …